Organization
Erasmus MC, University Medical Center Rotterdam, Department of Immunology, Rotterdam, Netherlands
1 abstract
Abstract
AMLEXANOX INHIBITS PRODUCTION OF TYPE I INTERFERON AND SUPPRESSES B CELL DIFFERENTIATION AND IMMUNOGLOBULIN PRODUCTION IN VITRO: A POTENTIAL NOVEL THERAPEUTIC OPTION FOR SLEOrg: Karolinska Institutet, Department of Medicine, Stockholm, Sweden, Academic Specialist Center, Center for Rheumatology, Stockholm, Sweden, Erasmus MC, University Medical Center Rotterdam, Department of Immunology, Rotterdam, Netherlands, Sophia Children’s Hospital, Erasmus MC, University Medical Center Rotterdam, Department of Paediatric Rheumatology, Rotterdam, Netherlands,